Asymmetric synthesis of anticancer β-lactams via Staudinger reaction

  • Authors:
    • Bimal K. Banik
    • Susanta Samajdar
    • Frederick F. Becker
  • View Affiliations

  • Published online on: March 1, 2010     https://doi.org/10.3892/mmr_00000259
  • Pages: 319-321
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

This study describes the symmetric synthesis of novel β-lactams derived from chrysene directed towards their SAR, as well as their biological activities against several cancer cell lines in vitro. To our knowledge, this is the first report on the synthesis and biological evaluation of optically active anticancer β-lactams. That these anticancer effects are not uniform against all tumor lines suggests that the target of the action of these compounds is highly specific.

Related Articles

Journal Cover

March-April 2010
Volume 3 Issue 2

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Banik BK, Samajdar S and Becker FF: Asymmetric synthesis of anticancer β-lactams via Staudinger reaction . Mol Med Rep 3: 319-321, 2010.
APA
Banik, B.K., Samajdar, S., & Becker, F.F. (2010). Asymmetric synthesis of anticancer β-lactams via Staudinger reaction . Molecular Medicine Reports, 3, 319-321. https://doi.org/10.3892/mmr_00000259
MLA
Banik, B. K., Samajdar, S., Becker, F. F."Asymmetric synthesis of anticancer β-lactams via Staudinger reaction ". Molecular Medicine Reports 3.2 (2010): 319-321.
Chicago
Banik, B. K., Samajdar, S., Becker, F. F."Asymmetric synthesis of anticancer β-lactams via Staudinger reaction ". Molecular Medicine Reports 3, no. 2 (2010): 319-321. https://doi.org/10.3892/mmr_00000259